Veloxis Pharmaceuticals A/S operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Veloxis Pharmaceuticals A/S with three other
miscellaneous service companies in Europe:
sales of 74.92 million Swedish Kronor [US$8.50 million]
Bioinvent International AB
(71.28 million Swedish Kronor [US$8.09 million]
based in France
(9.00 million Euro [US$9.72 million]